Hedge Fund - BioImpact Capital
Cullinan Therapeutics Inc. (CGEM)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $57,897,389 | 9.95% | 7,648,268 | $9.60 |
| 2 | 2024 - Q4 (2024-12-31) | $93,155,904 | 13.22% | 7,648,268 | $14.37 |
| 3 | 2024 - Q3 (2024-09-30) | $128,032,006 | 19.2% | 7,648,268 | $17.74 |
| 4 | 2024 - Q2 (2024-06-30) | $133,385,794 | 20.72% | 7,648,268 | $21.29 |
| 5 | 2024 - Q1 (2024-03-31) | $130,326,487 | 20.95% | 7,648,268 | $15.45 |
| 6 | 2023 - Q4 (2023-12-31) | $77,935,851 | 18.23% | 7,648,268 | $8.86 |
| 7 | 2023 - Q3 (2023-09-30) | $69,216,825 | 18.47% | 7,648,268 | $10.41 |
| 8 | 2023 - Q2 (2023-06-30) | $82,295,364 | 16.57% | 7,648,268 | $10.62 |
| 9 | 2023 - Q1 (2023-03-31) | $78,241,782 | 20.32% | 7,648,268 | $11.02 |
| 10 | 2022 - Q4 (2022-12-31) | $80,689,227 | 20.93% | 7,648,268 | $12.15 |
| 11 | 2022 - Q3 (2022-09-30) | $98,051,000 | 23.22% | 7,648,268 | $13.47 |
| 12 | 2022 - Q2 (2022-06-30) | $98,051,000 | 27.23% | 7,648,268 | $11.34 |
| 13 | 2022 - Q1 (2022-03-31) | $80,077,000 | 21.49% | 7,648,268 | $13.51 |
| 14 | 2021 - Q4 (2021-12-31) | $118,013,000 | 21.51% | 7,648,268 | $19.95 |
| 15 | 2021 - Q3 (2021-09-30) | $172,621,000 | 26.77% | 7,648,268 | $26.74 |
| 16 | 2021 - Q2 (2021-06-30) | $203,783,000 | 33.47% | 7,913,887 | $30.75 |
| 17 | 2021 - Q1 (2021-03-31) | $329,772,000 | 41.43% | 7,913,887 | $40.60 |
The displayed share prices are average quarterly stock market prices.